Latest Financial Reporting News

Evolution Mining Limited has announced a fully franked ordinary dividend of AUD 0.07 per share for the half-year ending December 2024, accompanied by a Dividend Reinvestment Plan offering a 5% discount.

Bravura Solutions Limited has announced an ordinary and special dividend totaling AUD 0.1052 per share for the financial year ending December 2024, signaling steady shareholder returns despite an unfranked payout.

Pro Medicus Limited has reported a robust half-year financial performance for the period ending December 31, 2024, with net profit soaring 42.7% and an increased interim dividend declared.

Viva Leisure Limited has reported a robust increase in net profit and net tangible assets for the half-year ended December 31, 2024, alongside gaining control of multiple fitness entities and launching a dividend reinvestment plan.

Domain Holdings Australia Limited has reported a robust half-year performance with a 10% increase in revenue and a 46.4% jump in net profit after tax for the period ending December 31, 2024. The company also announced a fully franked interim dividend, signaling confidence in its ongoing growth trajectory.

Regal Asian Investments Limited has reported a significant half-year loss of $23.6 million, reversing last year’s profit, while announcing an increased fully franked interim dividend of 6.0 cents per share and expanding its on-market share buy-back program.

Origin Energy has announced a fully franked ordinary dividend of AUD 0.30 per share for the six months ending December 2024, signaling steady shareholder returns.

Rewardle Holdings (RXH) confirms plans to lodge delayed financial reports by mid-February 2025, addressing audit complexities linked to its CloudHolter investment and ongoing partnership negotiations.

Sandon Capital Investments Limited reported a robust half-year performance with double-digit growth in revenue and profit, alongside a strategic shift to quarterly dividend payments starting March 2025.

IMDEX Limited reported a significant 84% increase in net profit for the half-year ended December 31, 2024, even as revenue declined by 10%. The company declared a steady interim dividend, underscoring confidence amid mixed financial signals.

SIV Capital Limited reported a sharp increase in losses for the half-year ending December 2024 and remains suspended from ASX trading due to operational concerns. The company is exploring acquisitions to leverage substantial tax losses and restore market confidence.

Argenica Therapeutics reported a 16% reduction in half-year losses to $1.19 million, buoyed by a 29% increase in other income largely from R&D tax incentives, as it advances its neuroprotective drug development.